The Effect of Arrhythmia Surgery on Quality of Life in Patients With Atrial Fibrillation Undergoing Cardiac Surgery

Not Applicable

Completed

• Conditions: Atrial Fibrillation

• Registration Number: NCT00886080
• Lead Sponsor: Maastricht University Medical Center

Brief Summary

Atrial fibrillation (AF) is connected with an increased morbidity and mortality. In addition, quality of life is diminished due to palpitations, dyspnea, dizziness and syncope. AF is frequently associated with valvular and coronary disease. In the AF patients undergoing valvular or coronary surgery the arrhythmia almost always relapses. For symptom control anti-arrhythmic drugs and cardioversion are used but breakthrough arrhythmias and side effects of the drugs happen frequently. For more effective symptom control "add-on" arrhythmia surgery is being advocated. However, at present the investigators do not know whether add-on arrhythmia surgery indeed affects morbidity and quality of life.

The hypothesis being studied is that add-on arrhythmia surgery in patients with AF undergoing valvular or coronary surgery improves quality of life, establishes chronic sinus rhythm and reduces perioperative and long-term morbidity associated with AF.

Detailed Description

Multicentre prospective parallel randomised controlled trial. In total 150 patients with documented atrial fibrillation (chronic and paroxysmal), were randomly assigned by a central computer system to undergo cardiac surgery with add-on surgery or without. This assignment was blinded to patients and all medical personnel except for the surgical team during total follow up. Patients completed quality of life questionnaires, comprising the RAND 36-item Health Survey 1.0 (SF-36), Multidimensional Fatigue Inventory-20 (MFI-20) and EuroQoL (EQ-5D and VAS) at baseline and 3, 6 and 12 months following operation.

Study Timeline

• Study Start: 2002-10
• Primary Completion: 2005-11
• Study Completion: 2005-11
• Status Verified: 2009-04
• Study First Submitted: 2009-04-20
• Study First Submitted QC: 2009-04-21
• Last Update Submitted: 2009-04-21
• Study First Posted: 2009-04-22
• Last Update Posted: 2009-04-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• Patients undergo valvular surgery and/ or coronary surgery,
• All patients have documented chronic atrial fibrillation of paroxysmal atrial fibrillation.
• Patients have given written informed consent.

Exclusion Criteria

• Patients who do not speak Dutch or can not read Dutch.
• Patients with a Sick Sinus Syndrome.
• Patients with contraindications for oral anticoagulant agents.
• Incompetent to act for oneself

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Quality of life and maintenance of sinus rhythm at 1 year will be considered as primary end points.	Baseline, 3, 6, and 12 months after operation

Secondary Outcome Measures

Name	Time	Method
In-hospital and out-of-hospital morbidity and mortality during one year follow-up	Baseline, 1, 6 and 12 months after operation

Trial Locations

Locations (1)

Dept. of Cardiothoracic Surgery, University Hospital Maastricht; 🇳🇱 Maastricht, Netherlands